De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cross Country Healthcare Beheer
Beheer criteriumcontroles 3/4
De CEO Cross Country Healthcare's is John Martins, benoemd in Apr2022, heeft een ambtstermijn van 2.5 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 3.51M, bestaande uit 24.8% salaris en 75.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.46% van de aandelen van het bedrijf, ter waarde $ 2.09M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.4 jaar en 5.1 jaar.
Belangrijke informatie
John Martins
Algemeen directeur
US$3.5m
Totale compensatie
| Percentage CEO-salaris | 24.8% |
| Dienstverband CEO | 2.5yrs |
| Eigendom CEO | 0.5% |
| Management gemiddelde ambtstermijn | 3.4yrs |
| Gemiddelde ambtstermijn bestuur | 5.1yrs |
Recente managementupdates
Recent updates
Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market
Jul 31
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet
Feb 22Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)
Feb 09Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital
Oct 09Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?
Sep 13These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well
Aug 19Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)
Jun 26At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?
Jun 08Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?
Apr 28Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)
Mar 15Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching
Mar 02If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity
Jan 20Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet
Jan 05Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?
Oct 29Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital
Oct 14Paring My Cross Country Healthcare Gains
Sep 29Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?
Sep 26Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC
Sep 14Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet
Aug 21Cross Country Healthcare rises postmarket on $100M stock buyback program
Aug 16Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided
Aug 03Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?
Jun 16Buying Back In To Cross Country Healthcare
May 17Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$8m |
| Mar 31 2024 | n/a | n/a | US$46m |
| Dec 31 2023 | US$4m | US$869k | US$73m |
| Sep 30 2023 | n/a | n/a | US$102m |
| Jun 30 2023 | n/a | n/a | US$124m |
| Mar 31 2023 | n/a | n/a | US$156m |
| Dec 31 2022 | US$3m | US$647k | US$188m |
| Sep 30 2022 | n/a | n/a | US$227m |
| Jun 30 2022 | n/a | n/a | US$216m |
| Mar 31 2022 | n/a | n/a | US$175m |
| Dec 31 2021 | US$1m | US$397k | US$132m |
Compensatie versus markt: De totale vergoeding ($USD 3.51M ) John } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.40M ).
Compensatie versus inkomsten: De vergoeding van John is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
John Martins (56 yo)
2.5yrs
Tenure
US$3,511,756
Compensatie
Mr. John A. Martins has been the President, Chief Executive Officer and a Director of Cross-Country Healthcare, Inc. since April 02022. He had been the Group President of Delivery at Cross Country Healthca...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Non-Executive Chairman of the Board | 5.8yrs | US$310.00k | 1.93% $ 8.6m | |
| President | 2.5yrs | US$3.51m | 0.46% $ 2.0m | |
| Executive VP & CFO | 5.7yrs | US$1.50m | 0.71% $ 3.2m | |
| Chief Administrative Officer | 20.4yrs | US$1.18m | 0.52% $ 2.3m | |
| Group President of Delivery | no data | US$953.25k | 0.10% $ 457.0k | |
| Senior VP & Chief Accounting Officer | 1.9yrs | geen gegevens | 0.055% $ 241.6k | |
| Chief Information Officer | 3.4yrs | geen gegevens | 0.030% $ 133.1k | |
| Vice President of Investor Relations | 2.6yrs | geen gegevens | geen gegevens | |
| Director of Corporate Communications | no data | geen gegevens | geen gegevens | |
| Chief Marketing Officer | 3.6yrs | geen gegevens | geen gegevens | |
| Vice President of Corporate Development | no data | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | no data | geen gegevens | 0.072% $ 317.5k |
3.4yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CCRN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Non-Executive Chairman of the Board | 5.8yrs | US$310.00k | 1.93% $ 8.6m | |
| President | 2.5yrs | US$3.51m | 0.46% $ 2.0m | |
| Independent Director | 9.4yrs | US$240.00k | 0.28% $ 1.2m | |
| Lead Independent Director | 23yrs | US$268.75k | 0.57% $ 2.5m | |
| Independent Director | 17.4yrs | US$237.25k | 0.52% $ 2.3m | |
| Independent Director | 4.4yrs | US$225.00k | 0.099% $ 440.2k | |
| Independent Director | 1.8yrs | US$287.50k | 0.044% $ 193.8k | |
| Independent Director | 1.9yrs | US$231.25k | 0.044% $ 193.2k |
5.1yrs
Gemiddelde duur
63yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CCRN wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.1 jaar).